Opus Point Partners Fund Manager Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Type

Hedge Fund Manager

Location

New York NY US

Alternative Asset Classes

Established

2008

Firm Ownership

Investment Team Staff

Total Staff

Opus Point Partners is a hedge fund manager managing a long/short equity hedge fund that focuses on the healthcare and biotechnology sectors. The firm was founded in November 2008 by Dr. Lindsay A. Rosenwald and Michael S. Weiss. Rosenwald most recently co-founded Cougar Biotechnology, and previously managed Aries Funds where he focused on healthcare investments. Weiss managed Paramount Capital/Aries Funds alongside Rosenwald and later went on to form Access Oncology which was later acquired by Keryx Biopharmaceuticals in 2004.

Asset Class	No. of Funds Currently Managed	Strategies
Private Equity	-	-
Real Estate	-	-
Private Debt	-	-
Infrastructure	-	-
Natural Resources	-	-

Asset Class	No. of Funds Currently Managed	AuM	Date of AuM	Strategies
Hedge Funds	3			Long/Short Equity

Want to see more?

Request a demo for full access to this profile.

3 Known Decision Makers

Position	Location	Asset Class
Associate	New York, US	HF
Executive Chairman, Partner & Co-Portfolio Manager	New York, US	HF
Co-Founder,Partner,Principal,Manager & Co-Portfolio Manager	New York, US	HF

Showing 3 of 3 known decision makers at Opus Point Partners

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a Demo to see more

3 Hedge Funds Managed

Fund Name	Share Classes	Inception Date	Core Strategy	Status	Latest AUM
			Long/Short Equity	Active
			Long/Short Equity	Active
			Long/Short Equity	Active

Showing 3 of 3 hedge funds managed by Opus Point Partners